Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-1-4
pubmed:abstractText
It is estimated that 10%-25% of patients who start highly active antiretroviral therapy (HAART) experience immune reconstitution inflammatory syndrome (IRIS). Our objective was to determine the incidence, clinical spectrum, and predictors of IRIS in an ethnically diverse cohort of patients initiating HAART.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1537-6591
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
418-27
pubmed:meshHeading
pubmed-meshheading:16392092-Adult, pubmed-meshheading:16392092-African Continental Ancestry Group, pubmed-meshheading:16392092-Anti-HIV Agents, pubmed-meshheading:16392092-Antiretroviral Therapy, Highly Active, pubmed-meshheading:16392092-Asian Continental Ancestry Group, pubmed-meshheading:16392092-CD4-CD8 Ratio, pubmed-meshheading:16392092-Cohort Studies, pubmed-meshheading:16392092-European Continental Ancestry Group, pubmed-meshheading:16392092-Female, pubmed-meshheading:16392092-HIV Infections, pubmed-meshheading:16392092-Humans, pubmed-meshheading:16392092-Immune Tolerance, pubmed-meshheading:16392092-Incidence, pubmed-meshheading:16392092-Inflammation, pubmed-meshheading:16392092-Male, pubmed-meshheading:16392092-Retrospective Studies, pubmed-meshheading:16392092-Reverse Transcriptase Inhibitors, pubmed-meshheading:16392092-Risk Factors, pubmed-meshheading:16392092-Syndrome
pubmed:year
2006
pubmed:articleTitle
Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.
pubmed:affiliation
Department of HIV/Genitourinary Medicine, King's College London, Guy's, King's College and St. Thomas' Hospitals, London, United Kingdom.
pubmed:publicationType
Journal Article